Acta Oncologica · 2014 · 108 citations · 22 references
MedicineOncologyRadiation OncologyBreast OncologyClinical Radiation OncologyTreatment PlanningBreast Cancer RadiotherapyBreast Cancer-related LymphedemaBreast SurgeryRadiation TherapyRadiation Treatment PlanningShoulder DisordersArm MorbidityBreast Cancer ChemotherapyClinical Endpoints CorrelationClinical Toxicity EndpointsLogistic RegressionPost-mastectomy RadiotherapyShoulder MorbidityStiffness
PURPOSE: To explore the relationship between radiotherapy (RT) dose levels in the arm/shoulder region and arm/shoulder morbidity in breast cancer patients. MATERIAL AND METHODS: This study included 183 breast cancer patients who had received locoregional RT with or without chemotherapy and/or hormone treatment during the period 1998-2002. Individual RT dose level, reflected by dose-volume histograms (DVHs), for the shoulder joint and joining structures were obtained from archived CT-based RT plans. Individual median, mean and maximum arm/shoulder RT dose levels were extracted. Arm/shoulder morbidity was assessed 29-58 months after breast cancer treatment using the following clinical endpoints: arm pain, arm stiffness, swollen arm, use of arm, numbness, shoulder flexion and shoulder abduction difference, fibrosis and breast cancer-related lymphedema. The relationship between arm/shoulder RT dose level and these clinical endpoints was assessed by Spearman's correlation and multivariate logistic regression. RESULTS: Ninety-one percent of the included patients had some degree of arm/shoulder morbidity. Neither mean nor maximum RT dose level was associated with clinical endpoints. However, significant correlations (p < 0.05) were found between DVHs and arm stiffness, arm pain, use of arm and shoulder abduction difference, when arm/shoulder RT dose levels were approximately 15 Gy. CONCLUSIONS: Three-dimensional conformal locoregional RT for breast cancer results in long-term arm/shoulder morbidity. To minimize this risk, large shoulder volumes receiving RT doses of approximately 15 Gy should be reduced.
22
Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery
Rune Gärtner, Maj‐Britt Jensen, Jeanette K.S. Nielsen et al. · JAMA · 2009 · 896 citations
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis
Jeanne A. Petrek, Ruby T. Senie, Margaret Peters et al. · Cancer · 2001 · 683 citations · Full text
Nadine Housri, Bruce G. Haffty · Breast Diseases A Year Book Quarterly · 2012 · 396 citations